InterHealth Zychrome Beats Chromium in Insulin Management Study

InterHealth Nutraceuticals Inc. (Benicia, CA) reports that its patent-pending Zychrome brand chromium proved significantly more effective than standard chromium picolinate in a three-month clinical trial. Zychrome was deemed 1.4-fold and 2.0-fold more effective than chromium picolinate in controlling insulin levels and insulin functions respectively, according to the company.

InterHealth’s research was presented at the 52^nd American College of Nutrition Meeting held November 16–19.